179 related articles for article (PubMed ID: 33743166)
1. Human TERT promoter polymorphism rs2853669 is associated with cancers: an updated meta-analysis.
Aziz MA; Jafrin S; Islam MS
Hum Cell; 2021 Jul; 34(4):1066-1081. PubMed ID: 33743166
[TBL] [Abstract][Full Text] [Related]
2. Association between TERT rs2853669 polymorphism and cancer risk: A meta-analysis of 9,157 cases and 11,073 controls.
Liu Z; Wang T; Wu Z; Zhang K; Li W; Yang J; Chen C; Chen L; Xing J
PLoS One; 2018; 13(3):e0191560. PubMed ID: 29534075
[TBL] [Abstract][Full Text] [Related]
3. Polymorphisms in the telomerase reverse transcriptase promoter are associated with risk of breast cancer: A meta-analysis.
Li ZY; Dong YL; Feng Y; Zhang Z; Cao XZ
J Cancer Res Ther; 2016; 12(2):1040-4. PubMed ID: 27461695
[TBL] [Abstract][Full Text] [Related]
4. TERT Polymorphism rs2853669 Influences on Lung Cancer Risk in the Korean Population.
Yoo SS; Do SK; Choi JE; Lee SY; Lee J; Cha SI; Kim CH; Park JY
J Korean Med Sci; 2015 Oct; 30(10):1423-8. PubMed ID: 26425038
[TBL] [Abstract][Full Text] [Related]
5. Association between functional TERT promoter polymorphism rs2853669 and cervical cancer risk in South Indian women.
Vinothkumar V; Arun K; Arunkumar G; Revathidevi S; Ramani R; Bhaskar LVKS; Murugan AK; Munirajan AK
Mol Clin Oncol; 2020 May; 12(5):485-494. PubMed ID: 32257207
[TBL] [Abstract][Full Text] [Related]
6. Association between rs2853669 in TERT gene and the risk and prognosis of human cancer: a systematic review and meta-analysis.
Shen N; Lu Y; Wang X; Peng J; Zhu Y; Cheng L
Oncotarget; 2017 Aug; 8(31):50864-50872. PubMed ID: 28881610
[TBL] [Abstract][Full Text] [Related]
7. The TERT promoter SNP rs2853669 decreases E2F1 transcription factor binding and increases mortality and recurrence risks in liver cancer.
Ko E; Seo HW; Jung ES; Kim BH; Jung G
Oncotarget; 2016 Jan; 7(1):684-99. PubMed ID: 26575952
[TBL] [Abstract][Full Text] [Related]
8. Clinicopathological significance of the single nucleotide polymorphism, rs2853669 within the TERT promoter in papillary thyroid carcinoma.
Hirokawa T; Arimasu Y; Chiba T; Fujiwara M; Kamma H
Pathol Int; 2020 Apr; 70(4):217-223. PubMed ID: 31943527
[TBL] [Abstract][Full Text] [Related]
9. Increased lung cancer risk associated with the TERT rs2736100 polymorphism: an updated meta-analysis.
Yang J; Jiao S
Tumour Biol; 2014 Jun; 35(6):5763-9. PubMed ID: 24590268
[TBL] [Abstract][Full Text] [Related]
10. Prognostic quality of activating TERT promoter mutations in glioblastoma: interaction with the rs2853669 polymorphism and patient age at diagnosis.
Spiegl-Kreinecker S; Lötsch D; Ghanim B; Pirker C; Mohr T; Laaber M; Weis S; Olschowski A; Webersinke G; Pichler J; Berger W
Neuro Oncol; 2015 Sep; 17(9):1231-40. PubMed ID: 25681309
[TBL] [Abstract][Full Text] [Related]
11. Discriminating association of a common telomerase reverse transcriptase promoter polymorphism with telomere parameters in non-small cell lung cancer with or without epidermal growth factor receptor mutation.
Yuan P; Huang S; Bao FC; Cao JL; Sheng HX; Shi L; Lv W; Hu J
Eur J Cancer; 2019 Oct; 120():10-19. PubMed ID: 31446212
[TBL] [Abstract][Full Text] [Related]
12. Association between TERT promoter polymorphisms and acute myeloid leukemia risk and prognosis.
Mosrati MA; Willander K; Falk IJ; Hermanson M; Höglund M; Stockelberg D; Wei Y; Lotfi K; Söderkvist P
Oncotarget; 2015 Sep; 6(28):25109-20. PubMed ID: 26298771
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of possible role of the h
Yalınbaş Kaya B; Ülger Y
Nucleosides Nucleotides Nucleic Acids; 2022; 41(10):961-971. PubMed ID: 35704667
[TBL] [Abstract][Full Text] [Related]
14. Ethnicity-specific association between TERT rs2736100 (A > C) polymorphism and lung cancer risk: a comprehensive meta-analysis.
Wu X; Huang G; Li W; Chen Y
Sci Rep; 2023 Aug; 13(1):13271. PubMed ID: 37582820
[TBL] [Abstract][Full Text] [Related]
15. Regulatory Single Nucleotide Polymorphism Increases TERT Promoter Activity in Thyroid Carcinoma Cells.
Hirokawa T; Arimasu Y; Chiba T; Nakazato Y; Fujiwara M; Kamma H
Pathobiology; 2020; 87(6):338-344. PubMed ID: 33227798
[TBL] [Abstract][Full Text] [Related]
16. Association between telomerase reverse transcriptase rs2736100 polymorphism and risk of glioma.
Zhou P; Wei L; Xia X; Shao N; Qian X; Yang Y
J Surg Res; 2014 Sep; 191(1):156-60. PubMed ID: 24888789
[TBL] [Abstract][Full Text] [Related]
17. Effect of single-nucleotide polymorphism in TERT promoter on follicular thyroid tumor development.
Hirokawa T; Arimasu Y; Nakazato Y; Chiba T; Fujiwara M; Kamma H
Pathol Int; 2020 Apr; 70(4):210-216. PubMed ID: 31943533
[TBL] [Abstract][Full Text] [Related]
18. The TERT MNS16A polymorphism contributes to cancer susceptibility: meta-analysis of the current studies.
Chen P; Zou P; Yan Q; Xu H; Zhao P; Gu A
Gene; 2013 May; 519(2):266-70. PubMed ID: 23462332
[TBL] [Abstract][Full Text] [Related]
19. TERT promoter mutations and rs2853669 polymorphism: prognostic impact and interactions with common alterations in glioblastomas.
Nencha U; Rahimian A; Giry M; Sechi A; Mokhtari K; Polivka M; Schmitt Y; Di Stefano AL; Alentorn A; Labussière M; Sanson M
J Neurooncol; 2016 Feb; 126(3):441-6. PubMed ID: 26608520
[TBL] [Abstract][Full Text] [Related]
20. COX-2 rs5275 and rs689466 polymorphism and risk of lung cancer: A PRISMA-compliant meta-analysis.
Li J; Lu X; Zou X; Jiang Y; Yao J; Liu H; Ni B; Ma H
Medicine (Baltimore); 2018 Aug; 97(35):e11859. PubMed ID: 30170377
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
